A Review of the Past,Present,and Future Clinical Trials From The Children's Cancer Group

Cangir A. , Vietti TJ , Gehan EA , et al: Ewing's Sarcoma metastatic at diagnosis: Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 66:887-893,1990

Cangir A. , Vietti TJ , Gehan EA , et al: The results and comparisons of two intergroup Ewing's sarcoma studies for metastatic disease at diagnosis (IESS-MD-I and IESS-MD-II). Proc Am Soc Clin Oncol 7:256,1988 (abstr)

Schoedel K. , Dickman PS , Krailo M. , et al: Response to chemotherapy and prognosis in osseous Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET). Int J Surg Pathol 2:443, 1995 (suppl) (abst)

Grier H. , Krailo M. , Link M. , et al: Improved outcome in non-metastatic Ewing's sarcoma (EWS) and PNET of bone with the addition of ifosfamide (I) and etoposide (E) to vincristine (V), Adriamycin (Ad), cyclophosphamide (C), and actinomycin (A): A CCG and POG Report. Proc Am Soc Clin Oncol 13:42, 1994 (abstr)

Miser JS , Krailo M. , Meyers P. , et al: Metastatic Ewing's sarcoma(es) and primitive neuroectodermal tumor (PNET) of bone: Failure of new regimens to improve outcome. Proc Am Soc Clin Oncol 15:467, 1996

Ertel IJ , Baum E. , Bleyer WA , et al: High dose methotrexate followed by leucovorin compared to moderate dose methotrexate followed by lecovorin therapy in addition to Adriamycin, vincristine, and surgical and/or radiation therapy in the treatment of patients with primary and/or metastatic osteogenic sarcoma. Chemioterapia Oncological 2:239-252, 1978

Makley JT , Krailo M. , Ertel IJ , et al: The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: A report from the Children's Cancer Study Group. J Pediatr Surg 23:146-151, 1988

Krailo M. , Ertel I. , Morgan E. , et al: Treatment of patients with newly diagnosed metastatic osteosar

coma : A report from the Children's Cancer Group. Proc Int Soc Pediatr Oncol 17:235, 1985

Provisor AJ , Ettinger LJ , Nachman JB , et al: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group. J Clin Oncol 15:76-84, 1997'

Morgan E. , Baum E. , Bleyer WA , et al: Treatment of patients with metastatic osteogenic sarcoma: A report from the Children's Cancer Study Group. Cancer Treat Rep 68:661-654, 1984

Children's Cancer Group Study Committee Reports , Biannual Meeting Book, CCG-7942: A Randomized Phase III Evaluation of Intensified Vincristine, Doxorubicin, Cyclophosphamide, Ifosfamide, and Etoposide in the Treatment of Newly-Diagnosed Ewing's Sarcoma or PNET of Bone or Soft Tissue , November 1997, pp 306-311

Children's Cancer Group Study Committee Reports , Biannual Meeting Book, CCG-7951: Induction Chemotherapy Followed by Melphalan/Etoposide/TBl and Autologous Stem Cell Reconstitution for Patients with Newly-Diagnosed High-Risk Ewing's Sarcoma, November 1997, pp 313-314

Children's Cancer Group Study Committee Reports , Biannual Meeting Book, CCG-B9511: Minimal Residual Disease Detection in High-Risk Ewing's Sarcoma and PNET of Bone, November 1997, p 479

Children's Cancer Group Study Committee Reports , Biannual Meeting Book, CCG-7943: A Phase II Window to Topotecan in Children with Newly-Diagnosed Metastatic Osteosarcoma, November 1997, p 312

Children's Cancer Group Study Committee Reports , Biannual Meeting Book, CCG-7921: Trial of ADR, CDDP and MTX with and without Ifos, With and Without MTP-PE for the Treatment of Osteogenic Sarcoma, November 1997, pp 303-305

Children's Cancer Group Study Committee Reports, Biannual Meeting Book, CCG-B931 RBI and p53 Expression and Prognosis in Pediatric and Adolescent Osteosarcoma, November 1997, p 460